Stockreport

Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Co...

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF Lead investor Bartosz Lipinski, previously Head of Engineering at Solana Labs, will serve as a technical partner CUBE selected to secure storage, staking, and active De [Read more]